Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even ...

Brett A. Wall, Executive Vice President and President of Neuroscience at Medtronic plc (NYSE:MDT), a $118 billion market cap ...

chief medical officer of the Diabetes Group at Medtronic. "The data demonstrating the benefits of this system are compelling and I'm confident it will simplify diabetes care for both patients and ...

The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Medtronic executives outlined four categories where the company expects the highest growth from new products in the near term: cardiac ablation, renal denervation, neuromodulation and automated ...

Peralta will be responsible for leading worldwide manufacturing operations, including driving alignment of operations with ...

TD Cowen analyst Josh Jennings maintained a Buy rating on Medtronic (MDT – Research Report) today and set a price target of $95.00. The ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price target of ...

CEOs from Medtronic, Intuitive Surgical, Boston Scientific and Dexcom were on hand this week in San Francisco to discuss the ...